The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: panitumumab     Injury: Peripheral sensory neuropathy     Quarter: 2016Q3

Total Records: 8     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
88186503 PANITUMUMAB Peripheral sensory neuropathy ROCHE 0.00 0 20160913 DK
122329126 panitumumab Peripheral sensory neuropathy AMGEN 59.00 YR M 66 KG 20160811 JP
123861304 panitumumab Peripheral sensory neuropathy AMGEN 0.00 M 80 KG 20160813 JP
124904633 panitumumab Peripheral sensory neuropathy AMGEN 0.00 F 55 KG 20160711 JP
125383402 panitumumab Peripheral sensory neuropathy AMGEN 0.00 F 59 KG 20160909 JP
126918812 panitumumab Peripheral sensory neuropathy AMGEN 65.00 YR M 69 KG 20160906 JP
127567761 panitumumab Peripheral sensory neuropathy AMGEN 66.00 YR M 61 KG 20160917 JP
1185397513 panitumumab Peripheral sensory neuropathy AMGEN 76.00 YR M 53 KG 20160917 JP

Total Records: 8     Number of Pages: 1